Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols

Aerosol Science and Technology

Volumn 45, Issue 7, 2011, Pages 884-899

  Worth Longest, P ^a,b   Hindle, Michael ^b  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012432882     PISSN: 02786826     EISSN: 15217388     Source Type: Journal    
DOI: 10.1080/02786826.2011.566592     Document Type: Article

References (40)

1. Asgharian, B., Hofmann, W., and Bergmann, R. (2001). Particle Deposition in a Multiple-Path Model of the Human Lung. Aerosol Sci. Technol., 34:332–339.
2. Borgstrom, L., Olsson, B., and Thorsson, L. (2006).Degree of ThroatDeposition Can Explain the Variability in Lung Deposition of Inhaled Drugs. J. Aerosol. Med., 19:473–483.
3. Broday, D. M., and Georgopoulous, G. (2001). Growth and Deposition of Hygroscopic Particulate Matter in the Human Lung. Aerosol Sci. Technol., 34:144–159.
4. Byron, P. R., Delvadia, R. R., Longest, P. W., and Hindle, M. (2010). Stepping into the Trachea with Realistic Physical Models: Uncertainties in Regional Drug Deposition from Powder Inhalers. Resp. Drug Del. 2010, 1:215–224.
5. Cheng, Y. S., Fu, C. S., Yazzie, D., and Zhou, Y. (2001). Respiratory Deposition Patterns of Salbutamol pMDI with CFC and HFA-134a Formulations in a Human Airway Replica. J. Aerosol. Med., 14(2):255–266.
6. Cinkotai, F. F. (1971). The Behavior of Sodium Chloride Particles in Moist Air. J. Aerosol Sci., 2:325–329.
7. Clift, R., Grace, J. R., and Weber, M. E. (1978). Bubbles, Drops, and Particles. Academic Press, New York.
8. Ferron, G. A., Oberdorster, G., and Hennenberg, R. (1989). Estimation of the Deposition of Aerosolised Drugs in the Human Respiratory Tract Due to Hygroscopic Growth. J. Aerosol. Med., 2:271.
9. Finlay, W. H. (1998). Estimating the Type of Hygroscopic Behavior Exhibited by Aqueous Droplets. J. Aerosol. Med., 11(4):221–229.
10. Finlay, W. H. (2001). The Mechanics of Inhaled Pharmaceutical Aerosols. Academic Press, San Diego, CA.
11. Finlay, W. H., and Stapleton, K.W. (1995). The Effect on Regional Lung Deposition of Coupled Heat and Mass-Transfer between Hygroscopic Droplets and Their Surrounding Phase. J. Aerosol Sci., 26(4):655–670.
12. Green, D. W. (1997). Perry’s Chemical Engineers’ Handbook. McGraw-Hill, New York.
13. Haefeli-Bleuer, B., and Weibel, E. R. (1988). Morphometry of the Human Pulmonary Acinus. Anat. Rec., 220:401–411.
14. Hardaker, L. E. A., and Hatley, R. H. M. (2010). In Vitro Characterization of the I-neb Adaptive Aerosol Delivery (AAD) System. Aerosol Med. Pulmonary Drug Del., 23(S1): S11–S20.
15. Hindle, M., Byron, P. R., Jashnani, R. N., Howell, T. M., and Cox, K. A. (1998).High Efficiency Fine Particle Generation Using Novel Condensation Technology, in Proceedings of Respiratory Drug Delivery VI, R. N. Dalby, P. R. Byron, and S. J. Farr, eds., Interpharm Press, Inc., Buffalo Grove, IL, pp. 97–102.
16. Hindle, M., and Longest, P.W. (2010). Evaluation of Enhanced Condensational Growth (ECG) for Controlled Respiratory Drug Delivery in aMouth–Throat and Upper Tracheobronchial Model. Pharm Res., 27:1800–1811.
17. Hinds, W. C. (1999). Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. John Wiley and Sons, New York.
18. Leach, C. L., Davidson, P. J., and Bouhuys, A. (1998). Improved Airway Targeting with the CFC-Free HFA-Beclomethasone Metered-Dose Inhaler Compared with CFC-Beclomethasone. Eur. Resp. J., 12:1346–1353.
19. Longest, P. W., and Hindle, M. (2009a). Evaluation of the Respimat Soft Mist Inhaler Using a Concurrent CFD and In Vitro Approach. J. Aerosol Med. Pulm. Drug Del., 22(2):99–112.
20. Longest, P. W., and Hindle, M. (2009b. Excipient Enhanced Growth (EEG) of Nanoparticle Aerosols to Enable Improved Pulmonary Targeting and Retention. Provisional US Patent Application.)
21. Longest, P.W., and Hindle, M. (2010). CFD Simulations of Enhanced Condensational Growth (ECG) Applied to Respiratory Drug Delivery with Comparisons to In Vitro Data. J. Aerosol Sci., 41:805–820.
22. Longest, P. W., Hindle, M., Das Choudhuri, S., and Byron, P. R. (2007). Numerical Simulations of Capillary Aerosol Generation: CFD Model Development and Comparisons with Experimental Data. Aerosol Sci. Technol., 41:952–973.
23. Longest, P.W., Hindle, M., Das Choudhuri, S., and Byron, P. R. (2008a). Developing a Better Understanding of Spray System Design Using a Combination of CFDModeling and Experiment, in Proceedings of Respiratory Drug Delivery 2008, R. N. Dalby, P. R. Byron, J. Peart, J. D. Suman, S. J. Farr, and P. M. Young, eds., Davis Healthcare International Publishing, River Grove, IL, pp. 151–163.
24. Longest, P. W., Hindle, M., Das Choudhuri, S., and Xi, J. (2008b). Comparison of Ambient and Spray Aerosol Deposition in a Standard Induction Port and More Realistic Mouth–Throat Geometry. J. Aerosol Sci., 39:572–591.
25. Longest, P.W., and Kleinstreuer, C. (2005). ComputationalModels for SimulatingMulticomponent Aerosol Evaporation in the UpperRespiratory Airways. Aerosol Sci. Technol., 39:124–138.
26. Longest, P. W., McLeskey, J. T., and Hindle, M. (2010). Characterization of Nanoaerosol Size Change during Enhanced Condensational Growth. Aerosol Sci. Technol., 44:473–483.
27. Longest, P.W., and Xi, J. (2008). Condensational Growth May Contribute to the Enhanced Deposition of Cigarette Smoke Particles in the Upper respiratory Tract. Aerosol Sci. Technol., 42:579–602.
28. Newman, S. (2009). Respiratory Drug Delivery: Essential Theory and Practice. RDD Online, Richmond, VA.
29. Newman, S. P., and Busse, W. W. (2002). Evolution of Dry Powder Inhaler Design, Formulation, and Performance. Resp. Med., 96:293–304.
30. Nikander, K., Prince, I., Coughlin, S., Warren, S., and Taylor, G. (2010). Mode of Breathing-Tidal or Slow and Deep-through the I-neb Adaptive Delivery (ADD) System Affects Lung Deposition of 99mTc-DTPA. J. Aerosol.Med., 23(S1):S37–S43.
31. Ninni, L., Camargo, M. S., and Meirelles, A. J. A. (2000). Water Activity in Polyol Systems. J. Chem. Eng. Data, 45:654–660.
32. Pitcairn, G., Reader, S., Pavia, D., and Newman, S. (2005). Deposition of Corticosteriod Aerosol in the Human Lung by Respimat Soft Mist Inhaler Compared to Deposition by Metered Dose Inhaler or by Turbuhaler Dry Power Inhaler. J. Aerosol. Med., 18(3):264–272.
33. Robinson, R., and Yu, C. P. (1998). Theoretical Analysis ofHygroscopicGrowth Rate of Mainstream and Sidestream Cigarette Smoke Particles in the Human Respiratory Tract. Aerosol Sci. Technol., 28:21–32.
34. Stahlhofen, W., Rudolf, G., and James, A. C. (1989). Intercomparison of Experimental Regional Aerosol Deposition Data. J. Aerosol. Med., 2(3):285–308.
35. Vargaftik, N. B. (1975). Tables on Thermophysical Properties of Liquids and Gases. Hemisphere, Washington, DC.
36. Varghese, S. K., and Gangamma, S. (2009). Particle Deposition in Human Respiratory System: Deposition of Concentrated Hygroscopic Aerosols. Inhal. Toxicol., 21(7):619–630.
37. Xi, J., Longest, P. W., and Martonen, T. B. (2008). Effects of the Laryngeal Jet on Nano-and Microparticle Transport and Deposition in an Approximate Model of the Upper Tracheobronchial Airways. J. Appl. Physiol., 104:1761–1777.
38. Zhang, Y., Gilbertson, K., and Finlay, W. H. (2007). In Vivo–In Vitro Comparison of Deposition in Three Mouth–Throat Models with Qvar and Turbuhaler Inhalers. J. Aerosol. Med., 20(3):227–235.
39. Zhang, Z., Kleinstreuer, C., and Kim, C. S. (2006a). Isotonic and Hypertonic Saline Droplet Deposition in a Human Upper Airway Model. J. Aerosol Med., 19(2):184–198.
40. Zhang, Z., Kleinstreuer, C., and Kim, C. S. (2006b).Water Vapor Transport and Its Effects on the Deposition of Hygroscopic Droplets in a Human Upper Airway Model. Aerosol Sci. Technol., 40:52–67.